Abstract:Motivation: Pre-mRNA cleavage and polyadenylation are essential steps for 30-end maturation and subsequent stability and degradation of mRNAs. This process is highly controlled by cis-regulatory elements surrounding the cleavage/polyadenylation sites (polyA sites), which are frequently constrained by sequence content and position. More than 50% of human transcripts have multiple functional polyA sites, and the specific use of alternative polyA sites (APA) results in isoforms with variable 30-untranslated regions, thus potentially affecting gene regulation. Elucidating the regulatory mechanisms underlying differential polyA preferences in multiple cell types has been hindered both by the lack of suitable data on the precise location of cleavage sites, as well as of appropriate tests for determining APAs with significant differences across multiple libraries.Results: We applied a tailored paired-end RNA-seq protocol to specifically probe the position of polyA sites in three human adult tissue types. We specified a linear-effects regression model to identify tissue-specific biases indicating regulated APA; the significance of differences between tissue types was assessed by an appropriately designed permutation test. This combination allowed to identify highly specific subsets of APA events in the individual tissue types. Predictive models successfully classified constitutive polyA sites from a biologically relevant background (auROC = 99.6%), as well as tissue-specific regulated sets from each other. We found that the main cis-regulatory elements described for polyadenylation are a strong, and highly informative, hallmark for constitutive sites only. Tissue-specific regulated sites were found to contain other regulatory motifs, with the canonical polyadenylation signal being nearly absent at brain-specific polyA sites. Together, our results contribute to the understanding of the diversity of post-transcriptional gene regulation.

Population-scale Genetic Control of Alternative Polyadenylation and Its Association with Human Diseases

Genetic Basis of Alternative Polyadenylation is an Emerging Molecular Phenotype for Human Traits and Diseases

Alternative polyadenylation mediates genetic regulation of gene expression

Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci

Large-scale alternative polyadenylation-wide association studies to identify putative cancer susceptibility genes

An Atlas of Alternative Polyadenylation Quantitative Trait Loci Contributing to Complex Trait and Disease Heritability

Alternative Polyadenylation: Methods, Mechanism, Function, and Role in Cancer.

Large-scale alternative polyadenylation (APA)-wide association studies to identify putative susceptibility genes in human common cancers

Impact of Rare Non-coding Variants on Human Diseases through Alternative Polyadenylation Outliers

Alternative Polyadenylation of Mrna and Its Role in Cancer

Immune-response 3′UTR Alternative Polyadenylation Quantitative Trait Loci Contribute to Variation in Human Complex Traits and Diseases

Genome-Wide Alternative Polyadenylation in Animals: Insights from High-Throughput Technologies

SNP2APA: a Database for Evaluating Effects of Genetic Variants on Alternative Polyadenylation in Human Cancers

Alternative Polyadenylation: Methods, Findings, and Impacts

Colocalization analysis of 3′ UTR alternative polyadenylation quantitative trait loci reveals novel mechanisms underlying associations with lung function

Using Population-Scale Transcriptomic and Genomic Data to Map 3′ UTR Alternative Polyadenylation Quantitative Trait Loci

Alternative Polyadenylation Quantitative Trait Loci Contribute to Acute Myeloid Leukemia Risk Genes Regulation

Genome-wide profiling reveals cancer-related genes with switched alternative polyadenylation sites in colorectal cancer.

A distinct class of pan-cancer susceptibility genes revealed by an alternative polyadenylation transcriptome-wide association study

mRNA alternative polyadenylation (APA) in regulation of gene expression and diseases

Genome-wide Identification and Predictive Modeling of Tissue-Specific Alternative Polyadenylation.